University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Sarah Arron, Ph.D., M.D.

Dermatologic surgeon

Dr. Sarah Arron, a dermatologic surgeon, is director of the High Risk Skin Cancer Program, which cares for patients who are at risk for skin cancer due to organ transplant, leukemia, lymphoma or genetic syndromes. She specializes in an advanced procedure called Mohs micrographic surgery to treat certain types of skin cancer. Arron also is an expert in facial reconstruction following surgery, laser surgery, dermatology for organ transplant recipients and for those with genetic risk factors for skin cancer. In addition, she performs cosmetic procedures including Botox and soft tissue fillers.

Arron's research interests include studying skin cancer, particularly in patients who are immunosuppressed. She earned a medical degree at Weill Medical College of Cornell University and a doctorate at The Rockefeller University. She completed a residency in dermatology and a fellowship in Mohs micrographic surgery and procedural dermatology at UCSF. Arron is an assistant professor in residence of dermatology at UCSF and the Helen Diller Family Comprehensive Cancer Center.

Clinics

Dermatologic Surgery and Laser Center
1701 Divisadero St.
San Francisco, CA 94115
Phone: (415) 353–7878
Fax: (415) 353–7838

Hours: Monday to Friday, 8 a.m. – 5 p.m.

High Risk Skin Cancer Clinic
1701 Divisadero St., Third Floor
San Francisco, CA 94143-0316
Phone: (415) 353-7830
Fax: (415) 353-7860

Hours: Friday by appointment

Melanoma Center
1600 Divisadero St.,
San Francisco, CA 94115
Phone: (415) 353-9900
Fax: (415) 885-3802

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

More about Sarah Arron

Education

Cornell University School of Medicine 2003

Residencies

UCSF Medical Center, Dermatology 2008

Fellowships

UCSF Medical Center, Procedural Dermatology 2007

Selected Research and Publications

  1. Makhzoumi ZH, Arron ST. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study. J Invest Dermatol. 2013 Aug; 133(8):1922-3.
  2. Ally MS, Tang JY, Arron ST. Cutaneous human papillomavirus infection and Basal cell carcinoma of the skin. J Invest Dermatol. 2013 Jun; 133(6):1456-8.
  3. Dimon MT, Wood HM, Rabbitts PH, Arron ST. IMSA: integrated metagenomic sequence analysis for identification of exogenous reads in a host genomic background. PLoS One. 2013; 8(5):e64546.
  4. Mihalis EL, Wysong A, Boscardin WJ, Tang JY, Chren MM, Arron ST. Factors affecting sunscreen use and sun avoidance in a U.S. national sample of organ transplant recipients. Br J Dermatol. 2013 Feb; 168(2):346-53.
  5. Wysong A, Linos E, Hernandez-Boussard T, Arron ST, Gladstone H, Tang JY. Nonmelanoma skin cancer visits and procedure patterns in a nationally representative sample: national ambulatory medical care survey 1995-2007. Dermatol Surg. 2013 Apr; 39(4):596-602.
  6. Gogia R, Binstock M, Hirose R, Boscardin WJ, Chren MM, Arron ST. Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation. J Am Acad Dermatol. 2013 Apr; 68(4):585-91.
  7. Aldabagh B, Angeles JG, Cardones AR, Arron ST. Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol Surg. 2013 Jan; 39(1 Pt 1):1-23.
  8. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Low JA, Mackey HM, Yauch RL, Graham RA, Reddy JC, Hauschild A. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012 Jun 7; 366(23):2171-9.
  9. Chong K, Daud A, Ortiz-Urda S, Arron ST. Cutting edge in medical management of cutaneous oncology. Semin Cutan Med Surg. 2012 Jun; 31(2):140-9.
  10. Singer JP, Boker A, Metchnikoff C, Binstock M, Boettger R, Golden JA, Glidden DV, Arron ST. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients. J Heart Lung Transplant. 2012 Jul; 31(7):694-9.
  11. Dybbro E, Mihalis E, Hirose R, Arron ST. Validity of patient skin cancer report among organ transplant recipients. Clin Transplant. 2012 Mar-Apr; 26(2):E132-6.
  12. Metchnikoff C, Mully T, Singer JP, Golden JA, Arron ST. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients. J Am Acad Dermatol. 2012 Nov; 67(5):829-35.
  13. Wang NJ, Sanborn Z, Arnett KL, Bayston LJ, Liao W, Proby CM, Leigh IM, Collisson EA, Gordon PB, Jakkula L, Pennypacker S, Zou Y, Sharma M, North JP, Vemula SS, Mauro TM, Neuhaus IM, Leboit PE, Hur JS, Park K, Huh N, Kwok PY, Arron ST, Massion PP, Bale AE, Haussler D, Cleaver JE, Gray JW, Spellman PT, South AP, Aster JC, Blacklow SC, Cho RJ. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A. 2011 Oct 25; 108(43):17761-6.
  14. Durinck S, Ho C, Wang NJ, Liao W, Jakkula LR, Collisson EA, Pons J, Chan SW, Lam ET, Chu C, Park K, Hong SW, Hur JS, Huh N, Neuhaus IM, Yu SS, Grekin RC, Mauro TM, Cleaver JE, Kwok PY, LeBoit PE, Getz G, Cibulskis K, Aster JC, Huang H, Purdom E, Li J, Bolund L, Arron ST, Gray JW, Spellman PT, Cho RJ. Temporal dissection of tumorigenesis in primary cancers. Cancer Discov. 2011 Jul; 1(2):137-43.
  15. Arron ST, Skewes-Cox P, Do PH, Dybbro E, Da Costa M, Palefsky JM, Derisi JL. Validation of a diagnostic microarray for human papillomavirus: coverage of 102 genotypes. J Nucleic Acids. 2011; 2011:756905.
  16. Arron ST, Jennings L, Nindl I, Rosl F, Bouwes Bavinck JN, SeÁkin D, Trakatelli M, Murphy GM. Viral oncogenesis and its role in nonmelanoma skin cancer. Br J Dermatol. 2011 Jun; 164(6):1201-13.
  17. Arron ST, Ruby JG, Dybbro E, Ganem D, Derisi JL. Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma. J Invest Dermatol. 2011 Aug; 131(8):1745-53.
  18. Ibrahim SF, Singer JP, Arron ST. Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole. Dermatol Surg. 2010 Nov; 36(11):1752-5.
  19. Erez N, Truitt M, Olson P, Arron ST, Hanahan D. Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. Cancer Cell. 2010 Feb 17; 17(2):135-47.
  20. Cowen EW, Nguyen JC, Miller DD, McShane D, Arron ST, Prose NS, Turner ML, Fox LP. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. J Am Acad Dermatol. 2010 Jan; 62(1):31-7.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.